OVERVIEW

11th Annual Virtual Comprehensive Hematology and Oncology Review Course is organized by the University of Washington School of Medicine (UWSOM) Continuing Medical Education (CME).

Date of original release: September 21, 2020
Termination date: October 30, 2021

What is the significance of the 11th Annual Virtual Comprehensive Hematology and Oncology Review Course?

Course Overview:
This CME webcast will address the data supporting guidelines, recommendations, and recent advances regarding therapeutic options for patients with solid tumors and malignant and benign hematologic disorders. On finishing this program, attendees will have a deeper knowledge of the pathogenesis, diagnostic evaluation, and therapeutic modalities available for a breadth of solid tumors and hematologic disorders. Learners will also be equipped with course material and self-assessment for CME and MOC credits.

What are the objectives of the 11th Annual Virtual Comprehensive Hematology and Oncology Review Course?

Course Objectives:
Upon fulfillment of this CME activity, attendees should be able to:
• Determine the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common malignant hematological diseases.
• Outline the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common solid tumor malignancies.
• Combine guideline-based treatments into clinical practice while personalizing care appropriately for the patient.
• Include novel therapeutic and diagnostic approaches into clinical practice as appropriate.

Additional details will be posted as soon as they are available.